Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.650
-0.050 (-1.85%)
At close: Apr 28, 2026, 4:00 PM EDT
2.640
-0.010 (-0.38%)
After-hours: Apr 28, 2026, 6:38 PM EDT
Cronos Group Revenue
In the year 2025, Cronos Group had annual revenue of $146.59M with 24.63% growth. Cronos Group had revenue of $44.53M in the quarter ending December 31, 2025, with 46.96% growth.
Revenue (ttm)
$146.59M
Revenue Growth
+24.63%
P/S Ratio
6.99
Revenue / Employee
$240,307
Employees
610
Market Cap
1.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 146.59M | 28.97M | 24.63% |
| Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
| Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
| Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
| Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.25B |
| Evotec SE | 925.65M |
| Tilray Brands | 858.28M |
| Collegium Pharmaceutical | 780.57M |
| Pacira BioSciences | 726.41M |
| Amphastar Pharmaceuticals | 719.89M |
| Alvotech | 588.90M |
| Ironwood Pharmaceuticals | 296.15M |
CRON News
- 4 days ago - Cronos Group (CRON) Sees Decline After Initial Surge on Marijuana Rescheduling News - GuruFocus
- 5 days ago - 'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana - Forbes
- 5 days ago - The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off - Market Watch
- 5 days ago - Cannabis rescheduling fuels optimism across industry - Reuters
- 5 days ago - Akanda (AKAN) Stock Continues Soaring Overnight Amid Trump Cannabis Reclassification Report: What You Should Know - Benzinga
- 6 days ago - Why are cannabis stocks surging today? - Invezz
- 6 days ago - Trump To Reclassify Marijuana 'As Soon As Wednesday,' But Prediction Markets Are Skeptical - Benzinga
- 8 days ago - Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026 - GlobeNewsWire